Anthrax -- United States
The US Food and Drug Administration today [23 Nov 2015] approved a new indication for BioThrax (anthrax vaccine adsorbed) to prevent disease following suspected or confirmed exposure to _Bacillus anthracis_, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of
from HealthMap Global Disease Alerts http://bit.ly/1Xd6UBX
via http://bit.ly/1Xd6UBX
No comments:
Post a Comment